In reply to Dr. Chhabra, Dr. Mégarbane, and colleagues

Brian Patrick MurrayGeorgia Poison Center, Grady Hospital, Atlanta, GA, USA;Department of Emergency Medicine, Emory University School of Medicine, Atlanta, GA, USA;Air Force Institute of Technology, US Air Force, Wright Patterson AFB, OH, USACorrespondence[email protected]

http://orcid.org/0000-0002-7950-6762

Joseph E. CarpenterGeorgia Poison Center, Grady Hospital, Atlanta, GA, USA;Department of Emergency Medicine, Emory University School of Medicine, Atlanta, GA, USA

http://orcid.org/0000-0001-5487-6671

Camille A. DunkleyGeorgia Poison Center, Grady Hospital, Atlanta, GA, USA;Department of Emergency Medicine, Emory University School of Medicine, Atlanta, GA, USA

Tim P. MoranDepartment of Emergency Medicine, Emory University School of Medicine, Atlanta, GA, USA

Ziad KazziGeorgia Poison Center, Grady Hospital, Atlanta, GA, USA;Department of Emergency Medicine, Emory University School of Medicine, Atlanta, GA, USA

References

Chhabra N, Pallasch E, Wahl M, Bryant SM. Tramadol, naloxone, and seizures. Clinical toxicology (Philadelphia, Pa.). 2019 Mar 21:1.
Google Scholar
Mégarbane B, Gouda A, El Nabarawy N. Understanding the risk of seizure in tramadol overdose: still a long way to go. Clin Toxicol. 2019;1.
Web of Science ®Google Scholar
Murray BP, Carpenter JE, Dunkley CA, Moran TP, Alfaifi M, Alsukaiti WS, Kazzi Z. Seizures in tramadol overdoses reported in the ToxIC registry: predisposing factors and the role of naloxone. Clinical toxicology. 2019 Jan 25:1–5.
Google Scholar
Reimann W, Schneider F. Induction of 5-hydroxytryptamine release by tramadol, fenfluramine and reserpine. Eur J Pharmacol. 1998;349:199–203.
PubMed Web of Science ®Google Scholar
Beakley BD, Kaye AM, Kaye AD. Tramadol, pharmacology, side effects, and serotonin syndrome: a review. Pain Physician. 2015;18:395–400.
PubMed Web of Science ®Google Scholar
Eizadi-Mood N, Ozcan D, Sabzghabaee AM, et al. Does naloxone prevent seizure in tramadol intoxicated patients? Int J Prev Med. 2014;5:302–307.
PubMedGoogle Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

In reply to Dr. Chhabra, Dr. Mégarbane, and colleagues

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

In reply to Dr. Chhabra, Dr. Mégarbane, and colleagues

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date